Research on Parkinson's disease is currently working on various approaches to develop both causal and symptomatic therapies. The focus is primarily on improving motor skills and relieving non-motor symptoms.

Causal therapy: focus on alpha-synuclein

A promising approach in the causal therapy of Parkinson's is research into the protein alpha-synuclein, which forms abnormal deposits in the brain cells of Parkinson's patients. Research is being carried out on various active substances that can reduce or prevent these deposits.